Navidea Biopharmaceuticals, Inc.

NAVB · OTC
Analyze with AI
9/30/2023
6/30/2023
3/31/2023
12/31/2022
Assets
Cash & Equivalents$3,865$6,144$34$1,996
Short-Term Investments$0$0$0$0
Receivables$31$45$31$1
Inventory$461$461$461$427
Other Curr. Assets$147$355$672$780
Total Curr. Assets$4,503$7,005$1,198$3,204
Property Plant & Equip (Net)$119$142$148$156
Goodwill$0$0$0$0
Intangibles$1,065$1,062$1,011$1,000
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$12$12$12$12
Total NC Assets$1,196$1,215$1,170$1,168
Other Assets$0$0$0$0
Total Assets$5,699$8,220$2,368$4,372
Liabilities
Payables$2,071$2,008$3,171$2,123
Short-Term Debt$1,259$1,357$353$563
Tax Payable$0$0$0$0
Deferred Revenue$800$800$800$800
Other Curr. Liab.$4,310$4,141$4,926$6,457
Total Curr. Liab.$7,979$8,306$9,250$9,942
LT Debt$0$1$1,965$1,873
Deferred Rev, NC$700$700$700$700
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$700$701$2,665$2,573
Other Liabilities$0$0$0$0
Cap. Leases$11$20$11$20
Total Liabilities$8,679$9,006$11,915$12,515
Equity
Pref Stock$0$0$0$0
Common Stock$291$287$224$224
Retained Earnings-$385,909-$383,654-$389,479-$388,003
AOCI-$3,273-$1,079-$0$0
Other Equity$385,618$383,367$379,415$379,343
Total Equity-$3,273-$1,079-$9,840-$8,436
Supplemental Information
Minority Interest$293$293$293$293
Total Liab. & Tot. Equity$5,699$8,220$2,368$4,372
Net Debt-$2,605-$4,786$2,284$440